Acuta Capital Partners’s KalVista Pharmaceuticals KALV Stock Holding History

Acuta Capital Partners’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell
2019 Q4	$1.92M	Buy
2019 Q3	$290K	Sell
2019 Q2	$4.72M	Buy
2019 Q1	$5.88M	Buy
2018 Q4	$3.42M	Buy
2018 Q3	$2.85M	Buy